期刊文献+

伴有淋巴结转移的胸段食管鳞癌(T_(1~4)N1M0)患者155例的多因素生存分析 被引量:1

Survival analysis of 155 esophageal squamous carcinoma patients with metastastic lymph nodes(T_(1~4)N1M0)
下载PDF
导出
摘要 目的:探讨不同浸润深度及转移淋巴结数目对伴有淋巴结转移的胸段食管(N1)患者的预后影响,揭示同一病理分期下不同预后的病理基础及探讨合理的术后辅助治疗方案.方法:应用Cox模型及Kaplan-Meier生存曲线等对患者的术后临床病理及随访资料进行多因素分析.结果:155例患者,其中T1N1者2例,T2N1者46例,T3N1者103例,T4N1者4例.淋巴结转移数目小于4枚患者的(n=113)1,3,5 a生存率与大于4枚者(n=42)有统计学差异(P<0.05),患者的年龄、肿瘤部位等因素与术后生存无关(P>0.05).扩大的淋巴结清扫方式及目前不规范的术后辅助治疗未显现明显的生存获益.结论:转移淋巴结数目是影响患者预后及生存的重要因素.术后辅助治疗及扩大的淋巴结清扫方式对生存的改善则需要进一步多中心随机对照研究证实. AIM: To investigate the effect of tumor invasive depth and number of metastatic lymph nodes on the prognosis of patients with stage N1 thoracic esophageal squamous cell carcinoma and to explore the pathological mechanism of different prognosis and proper postoperative adjuvant therapy. METHODS : Clinieopathological and follow-up data of 155 patients, who had undergone simple resection of thoracic esophageal squamous cell carcinoma, were studied using Kaplan-Meier survival curves and Cox-model analysis. RESULTS: Among all the 155 cases, 2 were staged to T1N1,46 to T2N1, 103 to T3N1, and 4 to T4N1. The 1, 3 and 5-year survival rates of patients who had less than 4 metastatic lymph nodes were significantly higher than those who had more than 4 ( P 〈 0.05 ). But, no obvious statistical signifi-cancé was found in sex, age, tumor site or cellular differentiation. CONCLUSION : The number of metastatic lymph nodes is a vital factor influencing the prognosis and survival of patients with tho-racic esophageal squamous cell carcinoma. However, multi-center randomized control test is needed to prove the benefit of postopera- tive treatment and extended lymph node dissection.
出处 《第四军医大学学报》 北大核心 2009年第4期347-350,共4页 Journal of the Fourth Military Medical University
基金 国家高科技计划(863)重大专项资助项目(2006AA02A403)
关键词 食管肿瘤 鳞状细胞 淋巴结状态 顸后 存活率分析 术后辅助治疗 esophageal neoplasms carcinoma, squamous cell lymph node status prognosis survival analysis postoperative treatment
  • 相关文献

参考文献3

二级参考文献22

  • 1孙克林,张汝刚,张大为,黄国俊,汪良骏,张德超,杨林,程贵余.食管癌淋巴结转移对手术治疗预后的影响[J].中华外科杂志,1995,33(4):222-224. 被引量:24
  • 2Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin, 2005, 55 : 74-108.
  • 3Tachibana M, Kinugasa S, Dhar DK, et al. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol, 1999, 72: 88-93.
  • 4Rice TW, Blackstone EH, Rybicki LA, et al. Refining esophageal cancer staging. J Thorac Cardiovasc Surg, 2003, 125: 1103-1113.
  • 5Takemura M, Osugi H, Takada N, et al. Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy. Oncol Rep, 2003, 10: 75-80.
  • 6Dutkowski P, Hommel G, Bottger T, et al. How many lymph nodes are needed for an accurate pN classification in esophageal cancer? Evidence for a new threshold value. Hepatogastroenterology, 2002, 49: 176-180.
  • 7Fraunberger L, Kraus B, Dworak O. Distribution of lymph nodes and lymph node metastases in esophageal carcinoma. Zentralbl Chir, 1996, 121: 102-105.
  • 8Griffiths EA,Brummell Z,Gorthi G. Tumor length as a prognostic factor in esophageal malignancy:univariate and multivariate survival analyses[J].Journal of Surgical Oncology,2006,(04):258-267.doi:10.1002/jso.20449.
  • 9Ueda Y,Shiozaki A,Itoi H. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas[J].Japanese Journal of Clinical Oncology,2006,(12):775-782.doi:10.1093/jjco/hyl105.
  • 10Rizk NP,Venkatraman E,Bains MS. American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma[J].Journal of Clinical Oncology,2007,(05):507-512.doi:10.1200/JCO.2006.08.0101.

共引文献121

同被引文献15

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部